Sotera Health (SHC) Liabilities and Shareholders Equity (2020 - 2026)
Sotera Health (SHC) posted quarterly Liabilities and Shareholders Equity of $3.2 billion for Q1 2026, up 4.47% year-over-year from $3.1 billion in Q1 2025, and down 0.84% on a QoQ basis from $3.3 billion in Q4 2025.
Sotera Health (SHC) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
Sotera Health (SHC) has reported Liabilities and Shareholders Equity for 7 consecutive years, with $3.2 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 4.47% year-over-year to $3.2 billion; the TTM figure through Mar 2026 stood at $12.9 billion (up 4.25% YoY), while the FY2025 annual figure was $3.3 billion, up 6.24% from the prior year.
- Liabilities and Shareholders Equity came in at $3.2 billion for Q1 2026 at Sotera Health, down from $3.3 billion in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $3.4 billion in Q1 2023, with the low at $2.8 billion in Q3 2022.
- Average Liabilities and Shareholders Equity over 5 years is $3.1 billion, with a median of $3.1 billion recorded in 2025.
- Across the five-year window, Liabilities and Shareholders Equity rose 20.4% in 2023 and retreated 10.38% in 2024, its largest moves.
- Year by year, Liabilities and Shareholders Equity stood at $3.1 billion in 2022, then increased by 0.41% to $3.1 billion in 2023, then declined by 1.88% to $3.1 billion in 2024, then increased by 6.24% to $3.3 billion in 2025, then retreated by 0.84% to $3.2 billion in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $3.2 billion, $3.3 billion, and $3.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 24.53 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 113.28 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 83.54 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 3.39 Bn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 2.61 Bn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 13.07 Bn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 29.68 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 6.56 Bn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 3.67 Bn |
| 10 | Sotera Health | 5.06 Bn | 4.74 Bn | 147.07 Mn | 3.24 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.24 Bn |
| Dec 31, 2025 | 3.26 Bn |
| Sep 30, 2025 | 3.19 Bn |
| Jun 30, 2025 | 3.22 Bn |
| Mar 31, 2025 | 3.10 Bn |
| Dec 31, 2024 | 3.07 Bn |
| Sep 30, 2024 | 3.15 Bn |
| Jun 30, 2024 | 3.06 Bn |
| Mar 31, 2024 | 3.06 Bn |
| Dec 31, 2023 | 3.13 Bn |
| Sep 30, 2023 | 3.04 Bn |
| Jun 30, 2023 | 3.07 Bn |
| Mar 31, 2023 | 3.41 Bn |
| Dec 31, 2022 | 3.12 Bn |
| Sep 30, 2022 | 2.81 Bn |
| Jun 30, 2022 | 2.84 Bn |
| Mar 31, 2022 | 2.84 Bn |
| Dec 31, 2021 | 2.79 Bn |
| Sep 30, 2021 | 2.74 Bn |
| Jun 30, 2021 | 2.85 Bn |